JNJ Johnson & Johnson

Price (delayed)

$165.3

Market cap

$434.6B

P/E Ratio

23.65

Dividend/share

$4.31

EPS

$6.99

Enterprise value

$456.22B

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
JNJ's price to earnings (P/E) is 67% lower than its 5-year quarterly average of 70.8
JNJ's equity is up by 10% year-on-year and by 2.2% since the previous quarter
Johnson & Johnson's net income has decreased by 7% QoQ but it has increased by 3.4% YoY
The EPS has contracted by 7% from the previous quarter but it has grown by 3.6% YoY

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.63B
Market cap
$434.6B
Enterprise value
$456.22B
Valuations
Price to earnings (P/E)
23.65
Price to book (P/B)
5.7
Price to sales (P/S)
4.55
EV/EBIT
22.24
EV/EBITDA
16.48
EV/Sales
4.77
Earnings
Revenue
$95.59B
EBIT
$20.52B
EBITDA
$27.69B
Free cash flow
$19.95B
Per share
EPS
$6.99
Free cash flow per share
$7.59
Book value per share
$29.02
Revenue per share
$36.35
TBVPS
$38.47
Balance sheet
Total assets
$177.72B
Total liabilities
$101.37B
Debt
$32.6B
Equity
$76.36B
Working capital
$19.03B
Liquidity
Debt to equity
0.43
Current ratio
1.42
Quick ratio
1.09
Net debt/EBITDA
0.78
Margins
EBITDA margin
29%
Gross margin
67.9%
Net margin
19.2%
Operating margin
23.5%
Efficiency
Return on assets
10.2%
Return on equity
24.9%
Return on invested capital
27.5%
Return on capital employed
15.4%
Return on sales
21.5%
Dividend
Dividend yield
2.61%
DPS
$4.31
Payout ratio
61.7%

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
-1.1%
1 week
-3.4%
1 month
-6%
1 year
-5.65%
YTD
-3.37%
QTD
-6.88%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$95.59B
Gross profit
$64.87B
Operating income
$22.43B
Net income
$18.37B
Gross margin
67.9%
Net margin
19.2%
The gross profit is up by 9% YoY
Johnson & Johnson's net margin has decreased by 8% from the previous quarter and by 3.5% YoY
Johnson & Johnson's operating margin has decreased by 7% YoY
Johnson & Johnson's net income has decreased by 7% QoQ but it has increased by 3.4% YoY

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
P/E
23.65
P/B
5.7
P/S
4.55
EV/EBIT
22.24
EV/EBITDA
16.48
EV/Sales
4.77
JNJ's price to earnings (P/E) is 67% lower than its 5-year quarterly average of 70.8
The EPS has contracted by 7% from the previous quarter but it has grown by 3.6% YoY
JNJ's equity is up by 10% year-on-year and by 2.2% since the previous quarter
JNJ's price to book (P/B) is 7% less than its last 4 quarters average of 6.1 and 3.4% less than its 5-year quarterly average of 5.9
JNJ's revenue is up by 7% year-on-year
The price to sales (P/S) is 5% less than the last 4 quarters average of 4.8

Efficiency

How efficient is Johnson & Johnson business performance
The company's return on equity fell by 9% QoQ and by 8% YoY
Johnson & Johnson's return on invested capital has decreased by 9% YoY and by 6% QoQ
The return on assets has declined by 8% since the previous quarter
The ROS has contracted by 6% YoY and by 4.4% from the previous quarter

Dividends

What is JNJ's dividend history
DPS
$4.31
Dividend yield
2.61%
Payout ratio
61.7%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 75% greater than its total liabilities
Johnson & Johnson's total liabilities has decreased by 5% YoY and by 2.2% from the previous quarter
The quick ratio has increased by 4.8% YoY and by 2.8% QoQ
Johnson & Johnson's debt is 57% less than its equity
JNJ's equity is up by 10% year-on-year and by 2.2% since the previous quarter
The company's debt to equity fell by 10% YoY and by 2.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.